Showing results (131-140 of 935) with videos related to
Sort By:
Pageof 94
Biochemical and Biophysical Research Communications|April 22, 2009
Activating mutations of N-WASP alter Shigella pathogenesisDavid A Adamovich, Fumihiko Nakamura, Austen Worth, et al.Stem Cells (Dayton, Ohio)|September 8, 2011
Concise review: managing genotoxicity in the therapeutic modification of stem cellsChristopher Baum, Ute Modlich, Gudrun Göhring, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2006
Retrovirus vectors: toward the plentivirus?Christopher Baum, Axel Schambach, Jens Bohne, et al.The Journal of Allergy and Clinical Immunology|April 30, 2018
Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative diseaseNeelam Panchal, Ben Houghton, Begona Diez, et al.Viruses|October 14, 2011
Gammaretroviral vectors: biology, technology and applicationTobias Maetzig, Melanie Galla, Christopher Baum, et al.Expert Opinion on Biological Therapy|June 10, 2010
Generation and genetic modification of induced pluripotent stem cellsAxel Schambach, Tobias Cantz, Christopher Baum, et al.Blood|December 11, 2012
SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative diseaseChristine Rivat, Claire Booth, Maria Alonso-Ferrero, et al.Human Gene Therapy|September 8, 2011
Human involucrin promoter mediates repression-resistant and compartment-specific LEKTI expressionWei-Li Di, Ekaterina Semenova, Fernando Larcher, et al.Blood|January 17, 2004
WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorptionYolanda Calle, Gareth E Jones, Chris Jagger, et al.Journal of Virology|January 30, 2009
Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapyKatarzyna Karwacz, Sayandip Mukherjee, Luis Apolonia, et al.Pageof 94